🔴 BeyondSpring is trading 7% down in pre-market after Q2 report flagged financing needs for DUBLIN-4

BeyondSpring is trading 7% down in pre-market at $0.78 after its August 14, 2026 second-quarter report highlighted ongoing losses, limited cash, and financing needs for the planned DUBLIN-4 Phase 3 trial.

• Reported a $1.8 million quarterly net loss and $6.5 million in cash and short-term investments as of June 30, 2026.
• Management cited difficulty raising sufficient financing as a material risk while prioritizing regulatory, operational, manufacturing, and financing preparations for DUBLIN-4 as a pre-revenue company.
• Shares fell 15.78% on August 14, suggesting continued earnings-related selling.